Bexil Corp
OTC:BXLC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Bexil Corp
OTC:BXLC
|
US |
|
Liaoning Port Co Ltd
SSE:601880
|
CN |
|
T
|
Tiandi Science & Technology Co Ltd
SSE:600582
|
CN |
|
Biomerica Inc
NASDAQ:BMRA
|
US |
|
JE Cleantech Holdings Ltd
NASDAQ:JCSE
|
SG |
|
S
|
Shanghai Wanye Enterprises Co Ltd
SSE:600641
|
CN |
Balance Sheet
Balance Sheet Decomposition
Bexil Corp
Bexil Corp
Balance Sheet
Bexil Corp
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
9
|
7
|
2
|
3
|
2
|
1
|
4
|
4
|
3
|
6
|
|
| Cash Equivalents |
9
|
7
|
2
|
3
|
2
|
1
|
4
|
4
|
3
|
6
|
|
| Total Receivables |
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
12
|
7
|
2
|
3
|
2
|
1
|
4
|
4
|
3
|
6
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
3
|
3
|
3
|
2
|
2
|
1
|
1
|
1
|
0
|
0
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
7
|
9
|
15
|
15
|
13
|
20
|
15
|
20
|
19
|
19
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
2
|
1
|
2
|
3
|
3
|
2
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
24
N/A
|
19
-22%
|
20
+3%
|
21
+7%
|
19
-7%
|
23
+20%
|
23
0%
|
27
+18%
|
25
-7%
|
28
+11%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
1
|
2
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Total Current Liabilities |
1
|
2
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
1
|
|
| Long-Term Debt |
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
6
N/A
|
2
-69%
|
1
-34%
|
1
-7%
|
1
+7%
|
1
-22%
|
0
-88%
|
0
-30%
|
0
N/A
|
1
N/A
|
|
| Equity | |||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
4
|
3
|
4
|
5
|
4
|
9
|
10
|
16
|
14
|
18
|
|
| Additional Paid In Capital |
15
|
16
|
16
|
15
|
15
|
14
|
14
|
12
|
12
|
10
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Total Equity |
18
N/A
|
17
-5%
|
18
+7%
|
20
+8%
|
18
-8%
|
22
+23%
|
23
+4%
|
27
+19%
|
25
-6%
|
27
+7%
|
|
| Total Liabilities & Equity |
24
N/A
|
19
-22%
|
20
+3%
|
21
+7%
|
19
-7%
|
23
+20%
|
23
0%
|
27
+18%
|
25
-7%
|
28
+11%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|